CCT a risk factor for glaucoma damage

Article

CCT a risk factor for glaucoma damage

Central corneal thickness (CCT) and corneal hysteresis could present a pressure-independent risk factor for glaucoma damage, according to a report in the May issue of the American Journal of Ophthalmology.

N.G. Congdon and colleagues from the John Hopkins University School of Medicine conducted an observational study of 230 patients undergoing measurements for hysteresis, on the Reichert Ocular Response Analyser, and CCT by ultrasonic pachymetry. Charts were reviewed to determine highest known intraocular pressure (IOP), target IOP, diagnosis, number of years with glaucoma, cup-to-disk ratio (CDR), mean defect, pattern standard deviation, glaucoma hemifield test and the presence or absence of visual field progression. Of the 230 patients (127 female, 103 male) 85% had a diagnosis of primary open-angle glaucoma (POAG) or suspected POAG.

The researchers found that lower corneal hysteresis values (p=0.03) were associated with visual field progression, but CCT was not. When axial length was included in the model, hysteresis was not a significant risk factor (p=0.09). Thinner CCT measurements were associated with a higher CDR but neither CCT nor hysteresis were linked with mean defect, pattern standard deviation or glaucoma hemifield test. Thinner CCT was associated with the state of glaucoma damage, as indicated by CDR, and axial length and corneal hysteresis were linked to progressive field worsening.

It was concluded that CCT and hysteresis may constitute a risk factor for glaucoma damage, related to the composition of the eye wall itself.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
© 2025 MJH Life Sciences

All rights reserved.